TITLE

Pulmonary hypertension in Hodgkin's disease

AUTHOR(S)
Exline, Matthew; Magro, Cynthia; Lin, Thomas; Sood, Namita
PUB. DATE
April 2007
SOURCE
Thorax;Apr2007, Vol. 62 Issue 4, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor about pulmonary hypertension in Hodgkin's disease is presented.
ACCESSION #
25021024

 

Related Articles

  • Primary Pulmonary Hypertension and Anorectic Drugs. Louis, W.J. // New England Journal of Medicine;02/11/99, Vol. 340 Issue 6, p480 

    A letter to the editor is presented in response to the article "Appetite-suppressant drugs and the risk of primary pulmonary hypertension" by Abenhaim and others which appeared in the February 13, 1997 issue.

  • Primary Pulmonary Hypertension and Anorectic Drugs. Abenhaim, Lucien; Rich, Stuart; Benichou, Jacques; Bégaud, Bernard // New England Journal of Medicine;02/11/99, Vol. 340 Issue 6, p480 

    A response is presented by Lucien Abenhaim, Stuart Rich, Jacques Benichou and Bernard Bégaud to a letter to the editor about their article "Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension" which appeared in the August 29, 1996 issue.

  • Signaling Molecules in Pulmonary Hypertension. Hoeper, Marius M. // New England Journal of Medicine;5/22/2003, Vol. 348 Issue 21, p2151 

    A letter to the editor is presented in response to the article "Signaling Molecules in Nonfamilial Pulmonary Hypertension," by L. Du and colleagues, in the February 6, 2003 issue of the "New England Journal of Medicine."

  • Signaling Molecules in Pulmonary Hypertension. Thistlethwaite, Patricia A.; Jamieson, Stuart W. // New England Journal of Medicine;5/22/2003, Vol. 348 Issue 21, p2151 

    A response by Patricia A. Thistlewaite and Stuart W. Jamieson to a letter to the editor about their article focusing on pulmonary hypertension is presented.

  • Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease. Klings, Elizabeth S.; Farber, Harrison W. // New England Journal of Medicine;6/10/2004, Vol. 350 Issue 24, p2521 

    A letter to the editor is presented in response to the article "Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease" by Mark T. Gladwin and colleagues in the February 26, 2007 issue.

  • Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease. Hassoun, Paul M.; Krishnan, Jerry A. // New England Journal of Medicine;6/10/2004, Vol. 350 Issue 24, p2521 

    A letter to the editor is presented in response to the article "Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease" by Mark T. Gladwin and colleagues in the February 26, 2007 issue.

  • Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease. Gladwin, Mark T.; Sachdev, Vandana; Ognibene, Frederick P. // New England Journal of Medicine;6/10/2004, Vol. 350 Issue 24, p2521 

    A letter to the editor is presented in response to the article "Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease" by Mark T. Gladwin and colleagues in the February 26, 2007 issue.

  • Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension. Hoeper, Marius M.; Welte, Tobias // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1091 

    A letter to the editor is presented in response to a study on the use of sildenafil citrate for pulmonary arterial hypertension by researcher Nazzareno Galiè and colleagues in the November 17, 2005 issue.

  • Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension. Izbicki, Gabriel; Rosengarten, Dror; Picard, Elie // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1091 

    A letter to the editor is presented in response to a study on the use of sildenafil citrate for pulmonary arterial hypertension by researcher Nazzareno Galiè and colleagues in the November 17, 2005 issue.

  • Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension. Kuschner, Ware G. // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1091 

    A letter to the editor is presented in response to a study on the use of sildenafil citrate for pulmonary arterial hypertension by researcher Nazzareno Galiè and colleagues in the November 17, 2005 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics